Clinical trial
Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial
NCT01810224 is registered in ClinicalTrials.gov with Onze Lieve Vrouw Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial
- Lead sponsor
- Onze Lieve Vrouw Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2013
- Completion date
- Not reported
- Enrollment
- 206 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.